The Daily Mail
By Jo MacFarlane
May 16, 2010

Women who use antidepressants while pregnant are being warned by health chiefs about the risks to their unborn child.

The Government’s medicines watchdog advised doctors there is an increased risk that babies will be born with a rare lung condition if expectant mothers take drugs such as Prozac and Seroxat.

The Medicines and Healthcare products Regulatory Agency (MHRA) is recommending they are monitored more carefully because of the risk of developing persistent pulmonary hypertension after birth.

The condition normally affects up to two in 1,000 births – but the latest research suggests the risk is more than doubled in women taking antidepressants, affecting five in 1,000 births. The life-threatening condition means infants do not adapt to breathing outside of the womb.

The risk is greater if the medicines known as SSRIs – a new generation of depression wonder drugs – are taken later in the pregnancy.

The warning comes five years after studies first showed there may be a link between the drugs and birth defects. The MHRA advised doctors not to prescribe the drugs to pregnant women unless necessary.

However, it was revealed last year that GPs were still prescribing them to women considering becoming pregnant.

Read entire article:  http://www.dailymail.co.uk/health/article-1278675/Pregnant-women-warned-antidepressants-danger-unborn-child.html?ito=feeds-newsxml

« Return to news items

News Feed

Related Posts

• Lawyers & Settlements—Mom Alert: Would you want a 68% Higher Risk of Miscarriage? (Antidepressants & Pregnancy study) (0)
• New Study—Taking Antidepressants While Pregnant More Than Doubles Risk of Miscarriage (1)
• Birth Defects Claims from Users of Paxil on the Rise (1)
• Antidepressants once seen as miracle drugs: now risks are becoming evident – U.S. courts to hear evidence (0)
• Medscape – Psychotropic Medications Linked to Serious Adverse Drug Reactions in Children (4)

Tags: antidepressants, babies, birth defects, depression, expectant mothers, infants, lung defects, Medicines and Healthcare Products Regulatory Agency, MHRA, persistent pulmonary hypertension, PPHN, pregnant women, prozac, psychiatric drugs, risks, Seroxat, SSRIs, unborn child

This entry was posted on Monday, May 17th, 2010 at 9:39 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.